Drug Administration Law

Drug Administration Law of the People’s Republic of China
中华人民共和国药品管理法

[Current Text: Chinese, English]

(adopted Sept. 20, 1984, effective July 1, 1985; revised Feb. 28, 2001, effective Dec. 1, 2001; amended and effective Dec. 28, 2013; amended and effective Apr. 24, 2015; revised Aug. 26, 2019, effective Dec. 1, 2019)

  • Status: Revision passed
  • Legislative Body (Vote): NPCSC (164–0–3)
  • Principal Drafter: State Administration for Market Regulation
  • Submitter: State Council
  • Legislative Plans
    • Five-year: 11th NPCSC Category I; 12th NPCSC Category II; 13th NPCSC Category I
    • Annual: 2019
  • Legislative History & Text
    • NPCSC deliberation – round #3 (final): Aug. 22–26, 2019 (Current Text ⇧)
    • NPCSC deliberation – round #2: Apr. 20–23, 2019 (Chinese only) 💬
    • NPCSC deliberation – round #1: Oct. 22–26, 2018 (Chinese only) 💬
  • Legislative Records [Gazette 2019(5): 771–798]
    • Explanation (Oct. 22, 2018)
    • Report on Status of Revision (Apr. 20, 2019)
    • Report on Results of Deliberation (Aug. 22, 2019)
    • Report on Suggestions for Revision (Aug. 25, 2019)
    • Presidential Order (Aug. 26, 2019)
  • Press Conference: NPCSC General Office (Aug. 26, 2019)

NPC Observer Coverage

Last updated: August 6, 2025, 09:59 EDT